Comparison of administration of tirofiban in the ambulance or in the cathlab in patients with acute myocardial infarction treated with primary angioplasty

Trial Profile

Comparison of administration of tirofiban in the ambulance or in the cathlab in patients with acute myocardial infarction treated with primary angioplasty

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2012

At a glance

  • Drugs Tirofiban (Primary)
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms AGIR2
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Jul 2012 Last checked against European Clinical Trials Database record.
    • 29 Mar 2009 Results were presented at the 58th Annual Scientific Session of the American College of Cardiology (ACC 2009).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top